Sign in

CIK 0001517022 · Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
208756903
Phone
617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. SC 13G Stake Amended Statement of Ownership
  2. 425 Deal Prospectus/Communication re Business Combination
  3. 425 Deal Prospectus/Communication re Business Combination
  4. 425 Deal Prospectus/Communication re Business Combination
  5. 8-K Event Executive or director change · Other events
  6. 425 Deal Prospectus/Communication re Business Combination
  7. 425 Deal Prospectus/Communication re Business Combination
  8. 425 Deal Prospectus/Communication re Business Combination
  9. 425 Deal Prospectus/Communication re Business Combination
  10. 10-Q Report Quarterly Report
  11. EFFECT Other Notice of Effectiveness
  12. 425 Deal Prospectus/Communication re Business Combination
  13. 424B3 Offering Prospectus
  14. 425 Deal Prospectus/Communication re Business Combination
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. S-4/A Deal Registration Statement - Business Combination
  18. UPLOAD Other SEC-generated Letter
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. S-4/A Deal Registration Statement - Business Combination

Page 28 of 45 · 886 filings